FAP and neoplasm: We discovered that although [68Ga]Ga-FAPI-04 has a higher binding affinity toward FAP and higher tumor uptake, both of our pyridine-based tracers have lower uptake in blood, muscle, and bone, leading to much higher tumor-to-background contrast ratios.